Drugs for COVID-19

All the following drugs are approved for the management of COVID-19, except

Hydroxychloroquine

Remdesivir

Molnupiravir

Nirmatrelvir

All the following are true regarding remdesivir, except

Associated with increase in ALT levels

Blocks the SARS-CoV-2 RNA-dependent RNA polymerase enzyme

Recommended for patients with mild to moderate COVID-19 symptoms

Given 200mg as bolus dose intravenously

All the following are true regarding molnupiravir, except

Given orally for a 5-day treatment course

Blocks viral RNA-dependent RNA-polymerase

Recommended for use in pregnant patients

Approved for patients with mild to moderate COVID-19 symptoms

All the following are true regarding nirmatrelvir, except

Given orally for a 5-day treatment course

Blocks viral RNA-dependent RNA-polymerase

Administered along with ritonavir to increase nirmatrelvir concentrations

Approved for patients with mild to moderate COVID-19 symptoms

All the following monoclonal antibodies are effective against all Omicron variants of COVID-19, except

Cilgavimab

Sotrovimab

Bebtelovimab

Tixagevimab

Time is Up!

Time's up

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Name *

Email *

Website

Comment *

Save my name, email, and website in this browser for the next time I comment.

Search for...